NCT03938363View on ClinicalTrials.gov

Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

June 13, 2022

Study Completion Date

June 13, 2022

Conditions
Cervical Dystonia, PrimaryBlepharospasm
Interventions
OTHER

Treadmill

Walk on the Biodex Gait Trainer (TM) 3 Treadmill for registration of gait parameters Gait parameters will be evaluated 5 weeks after Botulinum Toxin injection for the two experimental groups and 5 weeks after the first evaluation for the control groups

DRUG

Botulinum Toxin injection

injection of Botulinum Toxin in the two groups of CD and BS

DIAGNOSTIC_TEST

Severity scale of the disease

JRS for BS TWSTRS for CD

Trial Locations (1)

38700

CHU Grenoble Alpes, La Tronche

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT03938363 - Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia | Biotech Hunter | Biotech Hunter